These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33738026)

  • 1. The late arrival of coronavirus disease 2019 (COVID-19) in Chad: mitigating spread in Ndjamena focused on specific target population.
    Nodjikouambaye ZA; Adawaye C; Yandai FH; Bélec L
    Pan Afr Med J; 2020; 37():338. PubMed ID: 33738026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Late Arrival of Coronavirus Disease 2019 (COVID-19) in Africa: Mitigating Pan-continental Spread.
    Nachega J; Seydi M; Zumla A
    Clin Infect Dis; 2020 Jul; 71(15):875-878. PubMed ID: 32227121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of COVID-19 vaccine hesitancy in Chad: A cross-sectional study.
    Takoudjou Dzomo GR; Mbario E; Djarma O; Soumbatingar N; Madengar M; Djimera N; Djindimadje A; Nguemadjita C; Nassaringar G; Bernales M; Nangerngar T; Naissem D; Paningar E; Gomez-Virseda C; Lopez Barreda R; Robbins I; Cournil A; Visier L; Tuaillon E; Mennechet FJD
    Front Public Health; 2022; 10():1063954. PubMed ID: 36684864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of COVID-19 Pandemic on the Clinical Follow-Up of Patients Living with HIV in Chad: A Retrospective Monocentric Investigation.
    Glenet M; Takoudjou Dzomo GR; Nguemadjita C; Djimera N; Lebreil AL; N'Guyen Y; Andreoletti L
    Am J Trop Med Hyg; 2024 Feb; 110(2):387-390. PubMed ID: 38150732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
    Liu X; Shaw RH; Stuart ASV; Greenland M; Aley PK; Andrews NJ; Cameron JC; Charlton S; Clutterbuck EA; Collins AM; Dinesh T; England A; Faust SN; Ferreira DM; Finn A; Green CA; Hallis B; Heath PT; Hill H; Lambe T; Lazarus R; Libri V; Long F; Mujadidi YF; Plested EL; Provstgaard-Morys S; Ramasamy MN; Ramsay M; Read RC; Robinson H; Singh N; Turner DPJ; Turner PJ; Walker LL; White R; Nguyen-Van-Tam JS; Snape MD;
    Lancet; 2021 Sep; 398(10303):856-869. PubMed ID: 34370971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The necessity for intra-action reviews during the COVID-19 pandemic.
    Mayigane LN; de Vázquez CC; Vente C; Charles D; Copper FA; Bell A; Njenge HK; Schmidt T; Samhouri D; Htike MM; Kato M; Stephen M; Van Kerkhove MD; Chungong S
    Lancet Glob Health; 2020 Dec; 8(12):e1451-e1452. PubMed ID: 33038949
    [No Abstract]   [Full Text] [Related]  

  • 7. Aerosol transmission of SARS-CoV-2 by children and adults during the COVID-19 pandemic.
    Moschovis PP; Yonker LM; Shah J; Singh D; Demokritou P; Kinane TB
    Pediatr Pulmonol; 2021 Jun; 56(6):1389-1394. PubMed ID: 33624927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Coronavirus (SARS-CoV-2) Crossing Borders Beyond Cities, Nations, and Continents: Impact of International Travel.
    Arora P; Mrig S; Goldust Y; Kroumpouzos G; Karadağ AS; Rudnicka L; Galadari H; Szepietowski JC; Di Lernia V; Goren A; Kassir M; Goldust M
    Balkan Med J; 2021 Jul; 38(4):205-211. PubMed ID: 34274909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules.
    Choi JY; Lee YJ; Ko JH; Kim SH; Kim HJ; Lee HW; Jeong H; Kim TY; Jang YG; Hong HJ; Kim MS; Lee SE; Kim YG; Chung EJ; Lim H; Jang S; Kim K; Kim SS; Ahn JY; Choi JY; Kim YC; Park YS; Peck KR; Kim B
    Front Cell Infect Microbiol; 2022; 12():948014. PubMed ID: 35899050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge, Attitudes and Practices Regarding COVID‑19 in N'Djamena, Chad.
    Takoudjou Dzomo GR; Bernales M; López R; Djofang Kamga Y; Kila Roskem JP; Deassal Mondjimbaye F; Nanbolngar J; Modode R; Rongar R; Diba F; Toglengar M; Ongolo JP; Gómez-Vírseda C
    J Community Health; 2021 Apr; 46(2):259-266. PubMed ID: 33484402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of vaccine-induced neutralizing antibody titers and estimated protective immunity against wild-type SARS-CoV-2 and the Delta variant: A prospective nationwide cohort study comparing three COVID-19 vaccination protocols in South Korea.
    Nham E; Ko JH; Song KH; Choi JY; Kim ES; Kim HJ; Kim B; Lim HY; Kim KC; Jang HC; Lee KH; Song YG; Baek YJ; Ahn JY; Choi JY; Kim YC; Park YS; Choi WS; Bae S; Kim SH; Kang ES; Jeong HW; Kim SW; Kwon KT; Kim SS; Peck KR
    Front Immunol; 2022; 13():968105. PubMed ID: 36211416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients : A multicenter prospective observational study.
    Haase M; Lesny P; Anderson M; Cloherty G; Stec M; Haase-Fielitz A; Haarhaus M; Santos-Araújo C; Veiga PM; Macario F
    J Nephrol; 2022 Jun; 35(5):1467-1478. PubMed ID: 35084719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.
    Munro APS; Janani L; Cornelius V; Aley PK; Babbage G; Baxter D; Bula M; Cathie K; Chatterjee K; Dodd K; Enever Y; Gokani K; Goodman AL; Green CA; Harndahl L; Haughney J; Hicks A; van der Klaauw AA; Kwok J; Lambe T; Libri V; Llewelyn MJ; McGregor AC; Minassian AM; Moore P; Mughal M; Mujadidi YF; Murira J; Osanlou O; Osanlou R; Owens DR; Pacurar M; Palfreeman A; Pan D; Rampling T; Regan K; Saich S; Salkeld J; Saralaya D; Sharma S; Sheridan R; Sturdy A; Thomson EC; Todd S; Twelves C; Read RC; Charlton S; Hallis B; Ramsay M; Andrews N; Nguyen-Van-Tam JS; Snape MD; Liu X; Faust SN;
    Lancet; 2021 Dec; 398(10318):2258-2276. PubMed ID: 34863358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The COVID-19 pandemic in the African continent.
    Bwire G; Ario AR; Eyu P; Ocom F; Wamala JF; Kusi KA; Ndeketa L; Jambo KC; Wanyenze RK; Talisuna AO
    BMC Med; 2022 May; 20(1):167. PubMed ID: 35501853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2.
    Hassan AO; Kafai NM; Dmitriev IP; Fox JM; Smith BK; Harvey IB; Chen RE; Winkler ES; Wessel AW; Case JB; Kashentseva E; McCune BT; Bailey AL; Zhao H; VanBlargan LA; Dai YN; Ma M; Adams LJ; Shrihari S; Danis JE; Gralinski LE; Hou YJ; Schäfer A; Kim AS; Keeler SP; Weiskopf D; Baric RS; Holtzman MJ; Fremont DH; Curiel DT; Diamond MS
    Cell; 2020 Oct; 183(1):169-184.e13. PubMed ID: 32931734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review.
    Lv J; Wu H; Xu J; Liu J
    Infect Dis Poverty; 2022 May; 11(1):53. PubMed ID: 35562753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoonotic and Reverse Zoonotic Transmissibility of SARS-CoV-2.
    Goraichuk IV; Arefiev V; Stegniy BT; Gerilovych AP
    Virus Res; 2021 Sep; 302():198473. PubMed ID: 34118360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To mix or not to mix? A rapid systematic review of heterologous prime-boost covid-19 vaccination.
    Chiu NC; Chi H; Tu YK; Huang YN; Tai YL; Weng SL; Chang L; Huang DT; Huang FY; Lin CY
    Expert Rev Vaccines; 2021 Oct; 20(10):1211-1220. PubMed ID: 34415818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a Nationwide Lockdown on SARS-CoV-2 Transmissibility, Italy.
    Guzzetta G; Riccardo F; Marziano V; Poletti P; Trentini F; Bella A; Andrianou X; Del Manso M; Fabiani M; Bellino S; Boros S; Urdiales AM; Vescio MF; Piccioli A; ; Brusaferro S; Rezza G; Pezzotti P; Ajelli M; Merler S
    Emerg Infect Dis; 2021 Jan; 27(1):267-70. PubMed ID: 33080168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huge health needs for refugees in Chad.
    Samarasekera U
    Lancet; 2024 Feb; 403(10427):603. PubMed ID: 38368883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.